BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 30746369)

  • 1. Incidence, risk factors, and outcome of BK polyomavirus infection after kidney transplantation.
    Favi E; Puliatti C; Sivaprakasam R; Ferraresso M; Ambrogi F; Delbue S; Gervasi F; Salzillo I; Raison N; Cacciola R
    World J Clin Cases; 2019 Feb; 7(3):270-290. PubMed ID: 30746369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation.
    Elfadawy N; Flechner SM; Schold JD; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):553-61. PubMed ID: 24408118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis.
    Huang G; Wang CX; Zhang L; Fei JG; Deng SX; Qiu J; Li J; Chen GD; Fu Q; Chen LZ
    Diagn Microbiol Infect Dis; 2015 Jan; 81(1):21-6. PubMed ID: 25445121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for polyomavirus nephropathy and viremia in children with renal transplantation.
    Hamed R; Al Maghrabi M; Kasem MF; El Fekky MA; Al Shami AA; Mohamed NH; Sheyyab A
    Pediatr Transplant; 2023 May; 27(3):e14479. PubMed ID: 36724736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
    Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
    Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BK viremia surveillance and outcomes in simultaneous pancreas-kidney transplant recipients.
    Westphal SG; Lyden ER; Langewisch ED; Miles CD
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28509373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of BK polyomavirus nephropathy: 10-year analysis of 133 renal transplant recipients at a single center.
    Chen XT; Yang SC; Li J; Deng RH; Chen WF; Qiu J; Chen LZ; Wang CX; Huang G
    Chin Med J (Engl); 2019 Feb; 132(4):388-394. PubMed ID: 30707175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preemptive reduction of immunosuppression upon high urinary polyomavirus loads improves patient survival without affecting kidney graft function.
    Broeders EN; Hamade A; El Mountahi F; Racapé J; Hougardy JM; Le Moine A; Vereerstraeten P
    Transpl Infect Dis; 2016 Dec; 18(6):872-880. PubMed ID: 27615506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of BK virus surveillance on outcomes in kidney transplant recipients.
    Yoon SH; Cho JH; Jung HY; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
    Transplant Proc; 2015 Apr; 47(3):660-5. PubMed ID: 25891706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for BK Viremia/Viruria and the Impact of Management of BK Virus Nephropathy in Renal Transplant Recipients.
    Zakaria ZE; Elokely AM; Ghorab AA; Bakr AI; Halim MA; Gheith OA; Nagib AM; Makkeyah Y; Balaha MA; Magdy MM; Al-Otaibi T
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):83-91. PubMed ID: 30777529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Risk Factors of BK Viremia and Clinical Impact of BK Virus Surveillance on Outcomes in Kidney Transplant Recipients: A Single-Center Cross-Sectional Study.
    Ji J; Feng S; Jiang Y; Wang W; Zhang X
    Exp Clin Transplant; 2019 Dec; 17(6):727-731. PubMed ID: 30995893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study.
    Alméras C; Foulongne V; Garrigue V; Szwarc I; Vetromile F; Segondy M; Mourad G
    Transplantation; 2008 Apr; 85(8):1099-104. PubMed ID: 18431228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.
    Shah T; Vu D; Naraghi R; Campbell A; Min D
    Clin Transpl; 2014; ():109-16. PubMed ID: 26281134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of low-level BK polyomavirus viremia on intermediate-term renal allograft function.
    Korth J; Widera M; Dolff S; Guberina H; Bienholz A; Brinkhoff A; Anastasiou OE; Kribben A; Dittmer U; Verheyen J; Wilde B; Witzke O
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29156086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of DNA amplification with progress of BK polyomavirus infection and nephropathy in renal transplant recipients.
    Hasegawa M; Ito T; Saigo K; Akutsu N; Maruyama M; Otsuki K; Aoyama H; Matsumoto I; Asano T; Kitamura H; Kenmochi T
    Transplant Proc; 2014; 46(2):556-9. PubMed ID: 24656011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation.
    Elfadawy N; Flechner SM; Liu X; Schold J; Tian D; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
    Transpl Int; 2013 Aug; 26(8):822-32. PubMed ID: 23763289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor.
    Hässig A; Roos M; Etter A; Bossart W; Müller N; Schiesser M; Wüthrich RP; Fehr T
    Transpl Infect Dis; 2014 Feb; 16(1):44-54. PubMed ID: 24134704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients.
    Vu D; Shah T; Ansari J; Naraghi R; Min D
    Transplant Proc; 2015 Mar; 47(2):394-8. PubMed ID: 25769580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose steroid therapy in BK viremia adversely affected the long-term graft function after kidney transplantation.
    Kim H; Yu H; Baek CH; Han DJ; Park SK
    Transpl Infect Dis; 2016 Dec; 18(6):844-849. PubMed ID: 27622599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.